TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive US Preventive Services Task Force To Downgrade PSA Screening From “I” to “D” — As In “Don’t Do it.” October 6, 2011
TCL Archive In Brief; Burkitt, Epstein Will Divide Bristol-Myers Award; “Italian Nobel” Won By Columbia’s Sol Spiegelman March 26, 1982
TCL Archive In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs October 14, 1983